Approval marks the second generic semaglutide clearance in Canada and strengthens OneSource’s position in complex injectable CDMO programs
Approval expands Lupin’s specialty portfolio in the US market for treatment of urea cycle disorders
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
Several technologies for hemoglobinopathies are being transferred to commercial partners
_LOGO_256_384.jpg){kind=logo}
The association called for an end to the constant issuance of regulatory circulars that make operations unpredictable and capital-intensive.
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
Fredun received one-year contract worth Rs. 65 crores from a Southeast Asian country for Pharma exports
The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees
Candle Partners, an investment banking & advisory service for M&A among others, has closed many deals in the healthcare space. Ankit Poddar, Director, Candle Partners spoke to Thomas C Thottathil, Editor, Indianpharmapost.com about the prospects for the industry.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
